{"pub_date": "2016-07-28T00:00:00Z", "subsection_name": null, "lead_paragraph": "The pharmaceutical company won antitrust approval after agreeing to sell rights and assets related to 79 generic drugs to rival firms.", "print_page": null, "document_type": "article", "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "multimedia": [], "section_name": "Business Day", "headline": {"print_headline": "Teva Approved To Purchase  Allergan\u2019s Generics", "main": "Teva Is Approved to Purchase Allergan\u2019s Generics Business"}, "source": "The New York Times", "blog": [], "word_count": "210", "web_url": "http://www.nytimes.com/2016/07/28/business/teva-is-approved-to-purchase-allergans-generics-business.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The pharmaceutical company won antitrust approval after agreeing to sell rights and assets related to 79 generic drugs to rival firms....", "_id": "579942f738f0d87cf647e2dc", "abstract": null, "keywords": [{"rank": "1", "name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "N"}, {"rank": "2", "name": "organizations", "value": "Allergan Inc", "is_major": "N"}, {"rank": "3", "name": "subject", "value": "Antitrust Laws and Competition Issues", "is_major": "N"}, {"rank": "4", "name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}, {"rank": "6", "name": "subject", "value": "Generic Brands and Products", "is_major": "N"}, {"rank": "7", "name": "organizations", "value": "Federal Trade Commission", "is_major": "N"}]}